Natera, Inc. Company Profile

22:38 EDT 21st March 2018 | BioPortfolio

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA – as small as that from a single cell. Natera operates a CLIA laboratory in Redwood City, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include preimplantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an IVF cycle in order to select embryos with the highest probability of becoming healthy children; products of conception testing following miscarriage to rapidly and extensively analyze fetal chromosomes in order to understand the cause; and non-invasive prenatal testing to determine paternity or detect genetic disease by analyzing fragments of fetal DNA in a pregnant mother’s blood drawn in the first trimester. Non-invasive testing for paternity is currently available worldwide. Natera's clinical trial for non-invasive detection of chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. For more information, visit

News Articles [19 Associated News Articles listed on BioPortfolio]

Natera Inc. Announces Fourth Quarter and Fiscal 2017 Earnings Conference Call

Natera CEO Matthew Rabinowitzis also scheduled to present at the 38 thAnnual Cowen Healthcare Conference in Bostonon March 14, 2018at 7:40 Read more...

Natera est sélectionnée pour une étude longitudinale de l'ADN tumoral circulant dans le ...

Natera va travailler en partenariat avec des chercheurs financés par Cancer Research UK pour aider à identifier les biomarqueurs optimaux dans le cadre de la Read more...

QIAGEN und Natera kooperieren bei der Entwicklung hochmoderner genetischer Tests für den Einsatz auf QIAGENs GeneReader NGS-System

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) einem weltweit führenden Anbieter von Sample to Insight Lösungen, und Natera, Inc. (NASDAQ: NTRA) ein führender Entwickler von Next-Generati....

Natera selected for UK longitudinal breast cancer liquid biopsy study

Imperial College London and the University of Leicester have selected genetic testing company Natera for longitudinal circulating tumor DNA study in breast cancer.

Natera 2017 Q3 - Results - Earnings Call Slides

Natera 2017 Q4 - Results - Earnings Call Slides

QIAGEN and Natera Partner to Develop Cutting-Edge Genetic Testing Assays for Use on QIAGEN’s GeneReader NGS System

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of...

Natera's (NTRA) CEO Matthew Rabinowitz on Q4 2017 Results - Earnings Call Transcript

Drugs and Medications [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer

Natera is recruiting patients for a research study evaluating pregnancy and implantation rates in women undergoing In Vitro Fertilization (IVF) and Preimplantation Genetic Screening (PGS)....

Companies [2 Associated Companies listed on BioPortfolio]

Natera Inc.

Natera Inc. is a genetic testing company that specializes in analyzing microscopic quantities of DNA for reproductive health indications. The mission of the company is to help fam...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for...

More Information about "Natera, Inc." on BioPortfolio

We have published hundreds of Natera, Inc. news stories on BioPortfolio along with dozens of Natera, Inc. Clinical Trials and PubMed Articles about Natera, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Natera, Inc. Companies in our database. You can also find out about relevant Natera, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record